Diving shorts:

• Intuitive surgical Received CE mark confirmation For adults and children in Europe, many minimally invasive procedures, including urological, gynecological and general laparoscopic.
• The European Da Vinci 5 edition goes against the company’s forecasts. Director General Dave Rosa, who took the steering wheel on July 1 From Gary Guthart in April. During the income call, it was expected that Europe was expected to be expected in 2025. In the end, it is expected to be in Europe.
• The fifth generation system is the most advanced Pioneer robotics surgery with updates such as force feedback technology, improved visual system and more calculation power to improve patient performance and efficiency.

Diving insight:

DA Vinci 5 falls into the European market after the system Watched us closely debut 2024. At the beginning of the year. The system continues to expand the system in the US, where it is used in adult urology, general, gynecology and thoracic treatments.

April call Rosa said intuitive production operations and supply chain capabilities support the Midearear launch of the DA Vinci 5. Wide launch includes comprehensive integration of the company’s latest hardware and software and customer demand, including trade and double consoles, Rosa said.

Limited to the Da Vinci 5 installation passed faster than expected2024. There are strong company system practices.

Last year, surgeons used DA Vinci surgical systems in more than 410,000 procedures in Europe last year. The platform has supported nearly 17 million treatments around the world, intuitive said.

European approval is that intuitive is preparing for a larger competition in the soft tissue robotics market, and newcomers such as such as Moon surgical and CMR surgical Preparing to provide systems for the US market and a larger competitor at Medronic Monitors the approval of the Food and Pharmacy Administration;